Hyundai Pharm Working Capital to Net Assets Ratio
Hyundai Pharm working capital to net assets ratio. Hyundai Pharm (004310) has a Working Capital to Net Assets ratio of 34.6% as of May 2026. Working capital of ₩44.36 Billion (current assets of ₩108.45 Billion minus current liabilities of ₩64.09 Billion) is measured against net assets of ₩128.05 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Hyundai Pharm (2010–2025)
Working capital to net assets ratio of Hyundai Pharm from 2010 to 2025. This chart shows how Hyundai Pharm's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2010 to 2025. As of May 2026, the ratio stands at 34.6%, reflecting working capital of ₩44.36 Billion against net assets of ₩128.05 Billion KRW. Explore 004310 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Hyundai Pharm Working Capital to Net Assets Ratio by Year (2010–2025)
Hyundai Pharm working capital to net assets ratio by year from 2010 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Hyundai Pharm from 2010 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 004310 total asset value.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 11.5% | ₩9.42 Billion | ₩82.10 Billion | ₩80.83 Billion | ₩71.41 Billion | ▼ -14.9 pp |
| 2024 | 26.4% | ₩20.87 Billion | ₩79.07 Billion | ₩79.56 Billion | ₩58.69 Billion | ▲ +2.6 pp |
| 2023 | 23.8% | ₩20.14 Billion | ₩84.66 Billion | ₩85.47 Billion | ₩65.33 Billion | ▼ -0.4 pp |
| 2022 | 24.2% | ₩20.95 Billion | ₩86.56 Billion | ₩101.64 Billion | ₩80.70 Billion | ▼ -20.9 pp |
| 2021 | 45.1% | ₩39.05 Billion | ₩86.60 Billion | ₩84.90 Billion | ₩45.85 Billion | ▲ +13.2 pp |
| 2020 | 31.9% | ₩28.72 Billion | ₩90.14 Billion | ₩80.50 Billion | ₩51.78 Billion | ▲ +0.6 pp |
| 2019 | 31.3% | ₩27.40 Billion | ₩87.58 Billion | ₩71.64 Billion | ₩44.25 Billion | ▼ -11.5 pp |
| 2018 | 42.8% | ₩45.78 Billion | ₩107.00 Billion | ₩89.10 Billion | ₩43.32 Billion | ▲ +4.1 pp |
| 2017 | 38.6% | ₩37.91 Billion | ₩98.10 Billion | ₩86.93 Billion | ₩49.02 Billion | ▲ +0.8 pp |
| 2016 | 37.9% | ₩37.90 Billion | ₩100.08 Billion | ₩82.42 Billion | ₩44.52 Billion | ▼ -5.4 pp |
| 2013 | 43.3% | ₩43.83 Billion | ₩101.21 Billion | ₩80.48 Billion | ₩36.64 Billion | ▲ +0.8 pp |
| 2012 | 42.5% | ₩42.35 Billion | ₩99.69 Billion | ₩86.17 Billion | ₩43.82 Billion | ▲ +1.8 pp |
| 2011 | 40.7% | ₩42.45 Billion | ₩104.32 Billion | ₩87.51 Billion | ₩45.06 Billion | ▼ -5.6 pp |
| 2010 | 46.3% | ₩42.84 Billion | ₩92.50 Billion | ₩78.31 Billion | ₩35.47 Billion | — |